<DOC>
	<DOCNO>NCT01589146</DOCNO>
	<brief_summary>Overall , limited evidence exists regard clinical benefit antithrombotic prophylaxis laparoscopic surgery cancer . Four study report incidence venous thromboembolism ( VTE ) laparoscopic surgery cancer . These study differ concern study design , site cancer , regimens antithrombotic prophylaxis report incidence VTE . The aim multicenter , randomize study assess clinical benefit extend ( 4 week ) compare short ( one week ) heparin prophylaxis laparoscopic surgery colorectal cancer .</brief_summary>
	<brief_title>ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER .</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<criteria>Consecutive patient plan laparoscopic surgery colorectal cancer include study provide exclusion criterion find age &lt; 18 year surgery noncancer disease duration surgery &lt; 45 min indication anticoagulant therapy know cerebral metastasis kidney liver failure know hemorrhagic diathesis high risk bleed history intracerebral bleeding neurosurgery within 6 month , history heparin induce thrombocytopenia pregnancy lactation refusal inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>colon-rectal cancer</keyword>
	<keyword>heparin</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>laparoscopy</keyword>
</DOC>